Hello and welcome to IBA’s Full Year 2024 Results Conference Call. I am Thomas Pevenage, Head of Investor Relations of IBA. As usual, you will find this presentation on the Investor Relations page of ...

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency ...

Ion Beam Applications SA (IBA) showcased robust growth in its third quarter of 2024, with a significant increase in equipment order intake reaching EUR 215 million and a strong order book valued at ...

Belgian radiotherapy equipment manufacturer Ion Beam Applications S.A. (IBA) has acquired German PhantomX GmbH. This is reported in the IBA press release. The deal is aimed at expanding IBA's ...

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today ...

The average one-year price target for Ion Beam Applications (EBR:IBAB) has been revised to 24.53 / share. This is an increase of 9.15% from the prior estimate of 22.47 dated July 5, 2023. The price ...

As European markets demonstrate resilience, with the STOXX Europe 600 Index rising by 1.60% amid signs of steady economic growth and accommodating monetary policies, investors are increasingly turning ...

Helium ion beam (HIB) technology plays an important role in the extreme fields of nanofabrication. Due to high resolution and sensitivity, HIB nanofabrication technology is widely used to pattern ...

In a report released on November 21, Matthias Maenhaut from Kepler Capital maintained a Sell rating on Ion Beam Applications SA IBA (0GZK – Research Report), with a price target of €11.75. The company ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...